Carrie A H Vaudreuil1,2, Stephen V Faraone3, Maura Di Salvo1, Janet R Wozniak1,2, Rebecca A Wolenski1, Nicholas W Carrellas1, Joseph Biederman1,2. 1. Pediatric Psychopharmacology Program, Division of Child Psychiatry, Massachusetts General Hospital, Boston, Massachusetts. 2. Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts. 3. Department of Psychiatry and Behavioral Sciences, SUNY Upstate Medical University, Syracuse, New York.
Abstract
OBJECTIVE: The objective of this study was to evaluate the morbidity of subthreshold pediatric bipolar (BP) disorder. METHODS: We performed a systematic literature search in November 2017 and included studies examining the morbidity of pediatric subthreshold BP. Extracted outcomes included functional impairment, severity of mood symptoms, psychiatric comorbidities, suicidal ideation and behaviors, and mental health treatment. We used meta-analysis to compute the pooled standardized mean difference (SMD) for continuous measures and the pooled risk ratio (RR) for binary measures between two paired groups: subthreshold pediatric BP vs controls and subthreshold pediatric BP vs pediatric BP-I. RESULTS: Eleven papers, consisting of seven datasets, were included. We compared subthreshold pediatric BP (N = 244) to non-BP controls (N = 1125) and subthreshold pediatric BP (N = 643) to pediatric BP-I (N = 942). Subthreshold pediatric BP was associated with greater functional impairment (SMD = 0.61, CI 0.25-0.97), greater severity of mood symptomatology (mania: SMD = 1.88, CI 1.38-2.38; depression: SMD = 0.66, CI 0.52-0.80), higher rates of disruptive behavior (RR = 1.75, CI 1.17-2.62), mood (RR = 1.78, CI 1.29-2.79) and substance use (RR = 2.27, CI 1.23-4.21) disorders, and higher rates of suicidal ideation and attempts (RR = 7.66, CI 1.71-34.33) compared to controls. Pediatric BP-I was associated with greater functional impairment, greater severity of manic symptoms, higher rates of suicidal ideation and attempts, and higher rates of mental health treatment compared to subthreshold pediatric BP. There were no differences between full and subthreshold cases in the severity of depressive symptoms or rates of comorbid disorders. CONCLUSIONS: Subthreshold pediatric BP disorder is an identifiable morbid condition associated with significant functional impairment including psychiatric comorbidities and high rates of suicidality.
OBJECTIVE: The objective of this study was to evaluate the morbidity of subthreshold pediatric bipolar (BP) disorder. METHODS: We performed a systematic literature search in November 2017 and included studies examining the morbidity of pediatric subthreshold BP. Extracted outcomes included functional impairment, severity of mood symptoms, psychiatric comorbidities, suicidal ideation and behaviors, and mental health treatment. We used meta-analysis to compute the pooled standardized mean difference (SMD) for continuous measures and the pooled risk ratio (RR) for binary measures between two paired groups: subthreshold pediatric BP vs controls and subthreshold pediatric BP vs pediatric BP-I. RESULTS: Eleven papers, consisting of seven datasets, were included. We compared subthreshold pediatric BP (N = 244) to non-BP controls (N = 1125) and subthreshold pediatric BP (N = 643) to pediatric BP-I (N = 942). Subthreshold pediatric BP was associated with greater functional impairment (SMD = 0.61, CI 0.25-0.97), greater severity of mood symptomatology (mania: SMD = 1.88, CI 1.38-2.38; depression: SMD = 0.66, CI 0.52-0.80), higher rates of disruptive behavior (RR = 1.75, CI 1.17-2.62), mood (RR = 1.78, CI 1.29-2.79) and substance use (RR = 2.27, CI 1.23-4.21) disorders, and higher rates of suicidal ideation and attempts (RR = 7.66, CI 1.71-34.33) compared to controls. Pediatric BP-I was associated with greater functional impairment, greater severity of manic symptoms, higher rates of suicidal ideation and attempts, and higher rates of mental health treatment compared to subthreshold pediatric BP. There were no differences between full and subthreshold cases in the severity of depressive symptoms or rates of comorbid disorders. CONCLUSIONS: Subthreshold pediatric BP disorder is an identifiable morbid condition associated with significant functional impairment including psychiatric comorbidities and high rates of suicidality.
Authors: Franco De Crescenzo; Giulia Serra; Francesco Maisto; Mai Uchida; Hilary Woodworth; Maria Pia Casini; Ross J Baldessarini; Stefano Vicari Journal: J Am Acad Child Adolesc Psychiatry Date: 2017-08-03 Impact factor: 8.829
Authors: David Axelson; Robert L Findling; Mary A Fristad; Robert A Kowatch; Eric A Youngstrom; Sarah McCue Horwitz; L Eugene Arnold; Thomas W Frazier; Neal Ryan; Christine Demeter; Mary Kay Gill; Jessica C Hauser-Harrington; Judith Depew; Shawn M Kennedy; Brittany A Gron; Brieana M Rowles; Boris Birmaher Journal: J Clin Psychiatry Date: 2012-10 Impact factor: 4.384
Authors: Kathleen R Merikangas; Robert Jin; Jian-Ping He; Ronald C Kessler; Sing Lee; Nancy A Sampson; Maria Carmen Viana; Laura Helena Andrade; Chiyi Hu; Elie G Karam; Maria Ladea; Maria Elena Medina-Mora; Yutaka Ono; Jose Posada-Villa; Rajesh Sagar; J Elisabeth Wells; Zahari Zarkov Journal: Arch Gen Psychiatry Date: 2011-03
Authors: Christine A Demeter; Eric A Youngstrom; Gabrielle A Carlson; Thomas W Frazier; Brieana M Rowles; Jacqui Lingler; Nora K McNamara; Kathryn E Difrancesco; Joseph R Calabrese; Robert L Findling Journal: J Affect Disord Date: 2012-12-06 Impact factor: 4.839
Authors: Joseph Biederman; Janet Wozniak; Laura Tarko; Giulia Serra; Mariely Hernandez; Katie McDermott; K Yvonne Woodsworth; Mai Uchida; Stephen V Faraone Journal: J Affect Disord Date: 2013-10-07 Impact factor: 4.839
Authors: Rachel H B Mitchell; Vanessa Timmins; Jordan Collins; Antonette Scavone; Adam Iskric; Benjamin I Goldstein Journal: J Child Adolesc Psychopharmacol Date: 2016-02-04 Impact factor: 2.576
Authors: Ronald C Kessler; Shelli Avenevoli; Jennifer Green; Michael J Gruber; Margaret Guyer; Yulei He; Robert Jin; Joan Kaufman; Nancy A Sampson; Alan M Zaslavsky; Kathleen R Merikangas Journal: J Am Acad Child Adolesc Psychiatry Date: 2009-04 Impact factor: 8.829
Authors: Danella M Hafeman; Tina R Goldstein; Michael Strober; John Merranko; Mary Kay Gill; Fangzi Liao; Rasim S Diler; Neal D Ryan; Benjamin I Goldstein; David A Axelson; Martin B Keller; Jeffrey I Hunt; Heather Hower; Lauren M Weinstock; Shirley Yen; Boris Birmaher Journal: Bipolar Disord Date: 2021-01-19 Impact factor: 5.345